Condition 1: Malignant neoplasm of Thyroid. Condition 2: Benign tumor with solid mass. Condition 3: Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck. Malignant neoplasm of Thyroid Benign neoplasm of thyroid gland Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients candidate for Thyroid surgery Patients candidate for Parathyroid surgery Patients candidate for dissection of neck lymph nodes Patients candidate for Thyroid biopsy Patients candidate for neck lymph nodes biopsy
Exclusion criteria
Exclusion criteria: No exclusion criteria for patients candidate for Thyroid surgery High blood pressure patients (for ETS tests before biopsy) Patients taking anticoagulants (for ETS tests before biopsy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The pathologic classification of thyroid nodules or metastatic neck lymph nodes. Timepoint: before dissection of the thyroid nodule, suspicious lymph node or parathyroid nodule for patients candidate for surgery / before FNA or CNB from thyroid nodule or suspicious lymph nodes for patients candidate for biopsy. Method of measurement: Electrical Impedance Spectroscopy (impedance phase slope in frequency ranges of 100kHz to 500 kHz). | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigation of ETS in decreasing unrequired biopsy or surgery of benign thyroid lesions. Timepoint: after finishing the trial. Method of measurement: By comparing FNA pathology results and impedance spectroscopy results of patients candidate for thyroid surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences